Table 1.
Rho GTPases |
Pro- or anti- oncogenic |
Model | Remarks | References (year) |
---|---|---|---|---|
RhoC | Pro-oncogenic | RhoC−/−; pyV-MT mouse model of mammary tumor |
Loss of RhoC did not affect tumor development but decreases tumor cell motility and metastatic cell survival leading to a drastic inhibition of metastasis |
Hakem et al.47 (2005) |
Rac1 | Pro-oncogenic | Rac1flox/flox and LSL-K-RasG12D mouse, lung infections with adenovirus expressing Cre (Ad-Cre) |
Rac1 function is required for tumorigenesis in this oncogenic K-Ras-induced lung cancer model |
Kissil et al.50 (2007) |
Rac1 | Pro-oncogenic | Rac1flox/flox; K5-Cre mouse, treated with DMBA/TPA to induce skin tumors |
Rac1 is crucial for skin tumor formation and mice with keratinocyte-restricted deletion of Rac1 are resistant to skin tumor formation. |
Wang et al.52 (2010) |
Rac1 | Pro-oncogenic | LSL-K-RasG12D; K14-Cre:ER; Rac1WT/− mouse model of epidermal papilloma |
Active Rac1 level was high in this model and genetic removal of one Rac1 allele significantly impaired K- Ras induced oral papilloma growth |
Samuel et al.51 (2011) |
Rac1/Rac2 | Pro-oncogenic | Transplant of Low density bone marrow from Rac1flox/flox; Mx1-Cre or Rac2−/−; Mx1- Cre mouse, transfected with retrovirus expressing MLL-AF9 to induce leukemia. |
Rac2, but not Rac1, is critical to the initiation of acute myeloid leukemia in this model; however, loss of either Rac1 or Rac2 is sufficient to impair survival and growth of the transformed MLL-AF9 leukemia |
Mizukawa et al.54 (2011) |
RhoA/Rac1 | Pro-oncogenic | Oncogenic Ras driven eye hyperplasia /tumorigenesis in Drosophila (ey-GAL4; UAS-Ras85DV12) |
Rho1, Rac1 and RhoGEF2 were identified to enhance oncogenic Ras driven tumorigenesis in a genome-wide screen |
Brumby et al.31 (2011) |
RhoA | Pro-oncogenic | K-RasLA2-G12D mouse model of non-small cell lung cancer (NSCLC) |
Combined inhibition of the proteasome and ROCK robustly suppresses K-Ras mutant tumor growth |
Kumar et al.32 (2012) |
Rac1b | Pro-oncogenic | LSL-K-RasG12D; Rosa26-LSL-Rac1b mouse model of lung cancer, lung infection with adenovirus expressing Cre (Ad-Cre) |
Expression of Rac1b synergized with oncogenic K- Ras resulting in increased cellular proliferation and accelerated tumor growth. |
Zhou et al.64 (2013) |
Rac1 | Pro-oncogenic | Rac1flox/flox; K-Ras(LSL-G12D)/+; Ptf1acre/+ mouse model of pancreatic ductal adenocarcinoma (PDA) with pancreas- specific deletion of Rac1 |
Pancreas-specific deletion of Rac1 prevented the development of pancreatic tumors. |
Wu et al.53 (2014) |
Cdc42 | Pro-oncogenic | APCmin/+; Cdc42flox/flox; Vil-Cre or Catnb(ex3)/+; Cdc42flox/flox; Vil-Cre mouse model of colorectal cancer with intestinal epithelial cell specific Cdc42 deletion |
Reduction of Cdc42 alleviates the tumorigenicity of mutant intestinal cells carrying single APC or β- catenin mutations |
Sakamori et al.58 (2014) |
RhoA | Anti-oncogenic | TO(K-RasG12V/RhoA), TO(K- RasG12V/RhoAT19N), or TO(K- RasG12V/RhoAG14V) zebra fish model of hepatocellular carcinoma |
Liver enlargement and hepatocyte proliferation induced by tet-on-inducible, liver-specific expression K-RasG12V was augmented by dominant- negative RhoAT19N, but reduced by constitutive- active RhoAG14V. |
Chew et al.94 (2014) |
RhoA | Anti-oncogenic | APCmin/+; RhoAT19N/−; Vil-Cretg/− mouse model of colorectal cancer with expression of dominant-negative RhoAT19N |
RhoA inactivation contributes to colorectal cancer progression/metastasis, largely through the activation of Wnt/β-catenin signaling |
Rodrigues et al.97 (2014) |
RhoB | Anti-oncogenic | RhoB−/− mouse with cutaneous squamous cell carcinomas (SCC) induced with UVB |
RhoB deletion lowered the incidence of SCC precursor tumors following chronic exposure to UVB. |
Meyer et al.112 (2014) |
Rac1 | Pro-oncogenic | K14-ΔNLef1; K14-Rac1Q61L mouse model of sebaceous adenoma with epidermis- specific active Rac1 |
Active Rac1 did not change the incidence or frequency of tumors, but could suppress tumor cell differentiation and enable malignant progression of sebaceous tumors. |
Frances et al.56 (2015) |
RhoA/RhoC | Anti-oncogenic | LSL-K-RasG12D with RhoAflox/flox or RhoC−/− or both, mouse models of lung carcinoma induced by lung infection of adenovirus expressing Cre (Ad-Cre) |
Deletion of RhoA or RhoC alone did not suppress K- RasG12D induced lung adenoma initiation; rather, deletion of RhoA along accelerated lung adenoma formation. |
Zandvakili et al.98 (2015) |